Skip to main content
. 2010 Sep 7;6:803–811. doi: 10.2147/vhrm.s13441

Table 5.

Number of patients with an adverse drug reaction in the observation period

Total population (n = 8237) O20, A5 (patients, n) O40, A5 (patients, n) O40, A10 (patients, n) Total (patients, n)

Patients without ADR 4141 2472 1400 8013
Patients with ADR 91 54 79 226*
  Serious 5 4 3 13
  Not serious 86 50 76 213

Change in dose* O20, A5 (n, % of patients with ADRs) O40, A5 (n, % of patients with ADRs) O40, A10 (n, % of patients with ADRs) Total (n, % of patients with ADRs)

  Not changed 3 (1.33) 4 (1.78) 4 (1.78%) 11 (4.89%)
  Drug withdrawn 86 (38.22) 49 (21.78) 68 (30.22%) 204 (90.67%)**
  Dose reduced 1 (0.44) 1 (0.44) 6 (2.67%) 8 (3.56%)
  Dose increased 1 (0.44) 0 (0) 0 (0%) 1 (0.44%)
  Unknown 0 (0) 0 (0) 1 (0.44%) 1 (0.44%)

Notes:

*

Data from one patient not included;

**

One patient with unknown dose.

Abbreviation: ADRs, adverse drug reactions.